Figure 2
Figure 2. Skin lesions. LCH skin lesions in patient no. 2 disappeared after a few days of treatment with vemurafenib. Skin biopsy before treatment showing typical LCH infiltration of the epidermis and papillary dermis with CD1a+ histiocytes; the hypodermis is infiltrated by foamy CD68+CD1a− histiocytes (as in the peritoneal biopsy). Immunohistochemistry confirmed the expression of BRAF by histiocytes.

Skin lesions. LCH skin lesions in patient no. 2 disappeared after a few days of treatment with vemurafenib. Skin biopsy before treatment showing typical LCH infiltration of the epidermis and papillary dermis with CD1a+ histiocytes; the hypodermis is infiltrated by foamy CD68+CD1a histiocytes (as in the peritoneal biopsy). Immunohistochemistry confirmed the expression of BRAF by histiocytes.

Close Modal

or Create an Account

Close Modal
Close Modal